Market Research Logo

Carmell Therapeutics Corp - Product Pipeline Analysis, 2017 Update

Summary

Carmell Therapeutics Corp (Carmell) is a biotechnology company that develops and commercializes bone healing accelerants and tissue healing accelerants. Its pipeline portfolio encompasses adjunctive treatment for long bone fractures in Phase I and Phase II a; and adjunctive treatment for total joint replacement; enhancer and extender for demineralized bone spine; and tissue healing accelerants to reduce surgical site infections in colorectal surgery, sternotomy, cesarean section, and hysterectomy in preclinical phase. Carmell’s pipeline products are based on its patented plasma-based bioactive materials (PBMs). The PBMs consist of concentrated natural regenerative factors which facilitate healing in various surgical settings, and reduce infections. The company caters its products to surgical site infection and orthopedic markets. Carmell is headquartered in Pittsburgh, Pennsylvania, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Carmell Therapeutics Corp
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Carmell Therapeutics Corp Company Overview
Carmell Therapeutics Corp Company Snapshot
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
Carmell Therapeutics Corp – Pipeline Analysis Overview
Carmell Therapeutics Corp - Key Facts
Carmell Therapeutics Corp - Major Products and Services
Carmell Therapeutics Corp Pipeline Products by Development Stage
Carmell Therapeutics Corp Pipeline Products Overview
Bone Healing Accelerant - DBM Spine
Bone Healing Accelerant - DBM Spine Product Overview
Bone Healing Accelerant - Long Bone (Tibia) Fractures
Bone Healing Accelerant - Long Bone (Tibia) Fractures Product Overview
Bone Healing Accelerant - Total Joint Replacement
Bone Healing Accelerant - Total Joint Replacement Product Overview
REPAIR Surgical Scaffold
REPAIR Surgical Scaffold Product Overview
Tissue Healing Accelerant - C-Section/Hysterectomy
Tissue Healing Accelerant - C-Section/Hysterectomy Product Overview
Tissue Healing Accelerant - Colorectal Surgery
Tissue Healing Accelerant - Colorectal Surgery Product Overview
Tissue Healing Accelerant - Sternotomy
Tissue Healing Accelerant - Sternotomy Product Overview
Carmell Therapeutics Corp - Key Competitors
Carmell Therapeutics Corp - Key Employees
Carmell Therapeutics Corp - Locations And Subsidiaries
Head Office
Recent Developments
Carmell Therapeutics Corp, Recent Developments
Jun 22, 2017: Carmell Therapeutics announced the issuance of Canadian Patent No. 2701187 for Methods and Apparatus for Manufacturing Plasma Based Plastics
May 09, 2017: Carmell Therapeutics expands manufacturing capabilities to support Phase III clinical trials
Oct 05, 2016: Carmell Therapeutics New Management Team
Jun 24, 2016: Carmell announces the awarding of a new U.S. Patent that covers the use of the Company’s plasma-based materials as drug delivery vehicles
Apr 07, 2016: Dr. James Hart joins Carmell Therapeutics as new Chief Medical Officer
Feb 16, 2016: Carmell Therapeutics Announces Appointment of Randy Hubbell to President and Chief Executive Officer
May 15, 2015: Carmell Therapeutics’ Plasma-Based Materials Shown to be Effective Antibiotic Delivery Vehicles
Dec 23, 2014: Carmell Therapeutics Ends 2014 with Addition of a New Patent to its Growing Portfolio
Nov 14, 2014: Pittsburgh researchers' bone putty could revolutionize how broken bones mend
Oct 09, 2014: Paper Describing Carmell Therapeutics’ Clinical Data Receives Coveted GT du Toit Award from the South African Orthopaedic Association
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Carmell Therapeutics Corp Pipeline Products and Ongoing Clinical Trials Overview
Carmell Therapeutics Corp Pipeline Products by Equipment Type
Carmell Therapeutics Corp Pipeline Products by Indication
Carmell Therapeutics Corp, Key Facts
Carmell Therapeutics Corp, Major Products and Services
Carmell Therapeutics Corp Number of Pipeline Products by Development Stage
Carmell Therapeutics Corp Pipeline Products Summary by Development Stage
Bone Healing Accelerant - DBM Spine - Product Status
Bone Healing Accelerant - DBM Spine - Product Description
Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Status
Bone Healing Accelerant - Long Bone (Tibia) Fractures - Product Description
Bone Healing Accelerant - Total Joint Replacement - Product Status
Bone Healing Accelerant - Total Joint Replacement - Product Description
REPAIR Surgical Scaffold - Product Status
REPAIR Surgical Scaffold - Product Description
Tissue Healing Accelerant - C-Section/Hysterectomy - Product Status
Tissue Healing Accelerant - C-Section/Hysterectomy - Product Description
Tissue Healing Accelerant - Colorectal Surgery - Product Status
Tissue Healing Accelerant - Colorectal Surgery - Product Description
Tissue Healing Accelerant - Sternotomy - Product Status
Tissue Healing Accelerant - Sternotomy - Product Description
Carmell Therapeutics Corp, Key Employees
Glossary
List of Figures
Carmell Therapeutics Corp Pipeline Products by Equipment Type
Carmell Therapeutics Corp Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report